Prevalence of Atrial Fibrillation on a 24-hour Holter in Adult Indians.

Holter India paroxysmal atrial fibrillation

Journal

Indian heart journal
ISSN: 2213-3763
Titre abrégé: Indian Heart J
Pays: India
ID NLM: 0374675

Informations de publication

Date de publication:
13 Jun 2024
Historique:
received: 15 03 2024
revised: 31 05 2024
accepted: 12 06 2024
medline: 16 6 2024
pubmed: 16 6 2024
entrez: 15 6 2024
Statut: aheadofprint

Résumé

To evaluate paroxysmal atrial fibrillation (AF) prevalence in Indian adults who completed 24-Hour Holter monitoring. A total of 23,847 patients (36.9% women) were analyzed for AF duration using using a software algorithm. AF was diagnosed in 4,153 (17.4%) patients with a median AF duration of 13 minutes and 55 seconds. AF prevalence was high and largely untreated. The short duration of AF episodes indicates a low likelihood of detection during clinical visits, highlighting its potential underestimation in Indian healthcare.

Identifiants

pubmed: 38878964
pii: S0019-4832(24)00085-3
doi: 10.1016/j.ihj.2024.06.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier, a division of RELX India, Pvt. Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest ☐ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☒ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Willem verberk reports financial support was provided by Eris Lifesciences Pvt Ltd. corresponding author is an employee of Microlife corporation If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

M Srinivasa Rao (MS)

Apollo Hospital Hyderguda, Hyderabad, Telangana, India.

Ajit Mullasari (A)

Madras Medical Mission, Chennai, Tamil Nadu, India.

Jagdish S Hiremath (JS)

Ruby Hall Clinic, Pune, Maharashtra, India.

G Sengottuvelu (G)

Apollo Hospital, Greams Road, Chennai, India.

Aparna Jaiswal (A)

Fortis Escorts Heart Institute, New Delhi, India.

Darshan Jhala (D)

Lilavati Hospital, Mumbai, Maharashtra, India.

Jitendra Singh Makkar (JS)

Eternal Heart Care Centre and Research Institute, Jaipur, rajasthan, India.

B C Kalmath (BC)

Bombay Hospital Institute of Medical Science & Jupiter Hospital and Horizon group of Hospital, Thane, Maharashtra, India.

Bino Benjamin (B)

Jubilee Mission Medical College & Research Centre, Thrissur, Kerala, India.

Annirudha Dharmadhikari (A)

Shree Saibaba Heart Institute and Research Centre, Nashik, Maharashtra, India.

Mihir Tanna (M)

Olympus Hospital, Rajkot, Gujarat, India.

Aziz Khan (A)

Crescent Hospital & Heart Centre, Nagpur, Maharashtra, India.

Siddhant Jain (S)

Shalby Hospital, Indore, Madhya Pradesh, India.

K A Sambasivam (KA)

GKNM Hospital, Coimbatore, Tamil Nadu, India.

A Purnanand (A)

Purna Heart Institute, Vijayawada, Andhra Pradesh, India.

N S Rama Raju (NSR)

KIMS Hospital, Rajahmundry, Andhra Pradesh, India.

Goutam Sarkar (G)

RSV Hospital, Kolkata, West Bengal, India.

Hiren Prajapati (H)

Department of Medical Affairs, Eris Lifesciences Ltd., Ahmedabad,Gujarat, India.

Willem J Verberk (WJ)

CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands. Electronic address: willem.verberk@microlife.ch.

Classifications MeSH